acquired
Stage
1
Investors
About
Ashvattha Therapeutics was a United States-based biopharmaceutical company focused on the development of therapeutic drugs. It was part of Catalio Capital's portfolio and exited in 2019.
Explore Ashvattha Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.